![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
最近,世界上第一个数字健康项目Voreifarem建立在“医疗芯片 +区块链”(令牌缩写:IER)的核心建筑上,该项目正式在国际主流兼容的交易平台SWFCNRHO上正式推出。
New York, NY, May 05, 2025 (GLOBE NEWSWIRE) – Recently, Voreifarem (token abbreviation: IER), the world's first digital health project built on the core architecture of “medical chips + blockchain,” has officially launched on SwfcNrho, an international mainstream compliant trading platform. This listing has attracted significant attention from the industry, marking the entry of a new generation of medical blockchain projects—focusing on data ownership, user sovereignty, and compliance—into the global digital capital market.
纽约,纽约,2025年5月5日(Globe Newswire) - 最近,Vorifarem(令牌缩写:IER)是世界上第一个基于“医疗芯片 +区块链”的核心建筑,已正式在SWFCNRHO上正式启动,这是国际Mastream Compream Compriant Comprimant交易平台。该清单吸引了该行业的重大关注,标志着新一代的医疗区块链项目的进入(将数据所有权,用户主权和合规性都集中在全球数字资本市场中。
Since its launch, Voreifarem has received a strong market response, with trading volumes rapidly increasing and platform interest continuing to rise. Several professional research institutions believe that the project combines technological originality with real industrial value, making it a highly representative case of “industrial tokens” within the current Web 3.0 ecosystem. It is expected to achieve long-term value expansion in areas such as health data ownership, medical payment smart contracts, and AI health model authorization.
自推出以来,Voreifarem收到了强劲的市场反应,交易量迅速增加,平台兴趣持续上升。几家专业研究机构认为,该项目将技术独创性与实际工业价值相结合,使其成为当前Web 3.0生态系统中“工业代币”的高度代表性案例。预计将在健康数据所有权,智能合约和AI健康模型授权等领域实现长期价值的扩展。
Industry insiders point out that Voreifarem's ability to stand out in a competitive market is closely tied to its choice of SwfcNrho as its initial trading platform. As a leading compliant digital asset trading platform, SwfcNrho is registered in the United States and holds an MSB (Money Services Business) financial license issued by the U.S. Department of the Treasury's FinCEN, ensuring global compliance operations. The platform has a strict project review mechanism and a mature technical system, dedicated to promoting the legalization, transparency, and institutionalization of the global digital asset ecosystem. Its collaboration with Voreifarem reflects SwfcNrho's high recognition of the project's “long-term potential and practical implementation.”
行业内部人士指出,Voreifarem在竞争市场中脱颖而出的能力与选择SWFCNRHO作为最初的交易平台的能力紧密相关。作为领先的符合数字资产交易平台,SWFCNRHO在美国注册,并持有美国财政部Fincen美国签发的MSB(货币服务业务)财务许可证,以确保全球合规性运营。该平台具有严格的项目审查机制和一个成熟的技术系统,致力于促进全球数字资产生态系统的合法化,透明度和制度化。它与Voreifarem的合作反映了SWFCNRHO对该项目“长期潜力和实际实施”的高度认可。
SwfcNrho stated that it adheres to three core standards—“safety, compliance, and growth”—when selecting projects for listing, with particular emphasis on the underlying technology, industry adaptability, legal compliance, and the integration of “Web3 with reality.” Voreifarem not only has a strong foundation in medical data standardization and the construction of a DID identity system but also has built a complete blockchain infrastructure and incentive mechanism, making it a representative project in the integration of “medical technology and crypto finance.”
SWFCNRHO表示,它遵守三个核心标准:“安全,合规性和增长” - 选择用于上市的项目,特别强调了基本技术,行业适应性,法律合规性以及“ Web3与现实的整合”。 Voreifarem不仅在医疗数据标准化和DID身份系统的构建方面具有良好的基础,而且还建立了完整的区块链基础设施和激励机制,使其成为“医疗技术和加密货币融资”的代表性项目。
According to the Voreifarem project team, the platform will leverage the IER token to promote the global construction of medical data ownership and incentive mechanisms. Users will be able to upload their health data via smart chip terminals and receive IER incentives through a “chain-based ownership + authorized sharing + revenue return” mechanism, thereby realizing the innovative data economic structure of “personal health data as personal assets.” The platform will also engage in strategic partnerships with global wearable device manufacturers, insurance platforms, and research institutions to gradually build a new digital health ecosystem of “personal sovereign data networks + AI medical empowerment platforms.”
根据Voreifarem项目团队的说法,该平台将利用IER令牌来促进全球医疗数据所有权和激励机制的建设。用户将能够通过智能芯片终端上传其健康数据,并通过“基于链的所有权 +授权共享 +收入回报”机制获得IER激励措施,从而实现“个人健康数据作为个人资产”的创新数据经济结构。该平台还将与全球可穿戴设备制造商,保险平台和研究机构建立战略合作伙伴关系,以逐步建立一个新的数字健康生态系统,该系统是“个人主权数据网络 + AI医疗授权平台”。
As of now, SwfcNrho has established localized operational centers in New York, Lithuania, Dubai, and Singapore, supporting a multilingual, 24/7 service system. The platform has surpassed 3 million registered users globally, covering key markets in North America, Europe, Southeast Asia, the Middle East, and Africa. SwfcNrho has obtained multiple compliance qualifications, including the MSB license in Canada, VASP certification in Lithuania, and registration with Dubai VARA. It is also applying for the MAS payment license in Singapore and AUSTRAC registration in Australia, building a leading global compliance network for digital assets.
截至目前,SWFCNRHO已在纽约,立陶宛,迪拜和新加坡建立了本地化的运营中心,并支持了多种语言的24/7服务系统。该平台在全球范围内超过了300万注册用户,涵盖了北美,欧洲,东南亚,中东和非洲的主要市场。 SWFCNRHO已获得多个合规资格,包括加拿大的MSB许可证,立陶宛的VASP认证以及与迪拜Vara的注册。它还申请了新加坡和澳大利亚的Austrac注册的MAS支付许可证,建立了一个领先的全球数字资产合规性网络。
In addition, SwfcNrho continues to deepen its focus on financial security and infrastructure development. It has established global clearing partnerships with Citibank, HSBC, and Standard Chartered, and has engaged Deloitte for regular financial audits and reserve disclosures. The platform has integrated with compliance custodians like Anchorage Digital to provide bank-level security and asset isolation mechanisms for users and institutions.
此外,SWFCNRHO继续加深其对金融安全和基础设施发展的关注。它已经与花旗银行,汇丰银行建立了全球清算合作伙伴关系,并与特勤(Deloitte)进行了定期的财务审计和储备披露。该平台已与Anchorage Digital等合规托管人集成,为用户和机构提供银行级别的安全性和资产隔离机制。
Currently, SwfcNrho has opened liquidity services for the IER token in multiple markets, and interest in the Voreifarem project continues to grow. In the future, both parties will engage in deep collaboration around areas such as on-chain governance of health data, universal standards for cross-border medical data, and the construction of a compliant Web3 medical payment system, advancing the "medical blockchain" into a new phase of global industrialization.
目前,SWFCNRHO在多个市场中为IER代币开设了流动性服务,对Voreifarem项目的兴趣仍在不断增长。将来,双方将围绕诸如健康数据链治理,跨境医疗数据的通用标准以及构建合规的Web3医疗支付系统等领域进行深入的合作,将“医疗区块链”推向了全球工业化的新阶段。
Media contact
媒体联系
Contact: David L. Sanders
联系人:David L. Sanders
Company Name: SwfcNrho Ltd
公司名称:SWFCNRHO LTD
Website: https://trade.swfcnrho-ex.com
网站:https://trade.swfcnrho-ex.com
Email: Sanders11 at trade.swfcnrho-ex.com
电子邮件:sanders11在trade.swfcnrho-ex.com上
Media contact
媒体联系
Contact: Wilbur J. Hopkins
联系人:威尔伯·J·霍普金斯
Company Name: Voreifarem(IER)
公司名称:Voreifarem(IER)
Website: https://voreifarem.com
网站:https://voreifarem.com
Email: w.j.hopkins at voreifarem.com
电子邮件:voreifarem.com上的wjhopkins
Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities
免责声明:本新闻稿中提供的信息不是投资的招标,也不旨在作为投资建议,财务建议或交易建议。强烈建议您在投资或交易加密货币和证券之前练习尽职调查,包括与专业财务顾问的咨询
免责声明:info@kdj.com
所提供的信息并非交易建议。根据本文提供的信息进行的任何投资,kdj.com不承担任何责任。加密货币具有高波动性,强烈建议您深入研究后,谨慎投资!
如您认为本网站上使用的内容侵犯了您的版权,请立即联系我们(info@kdj.com),我们将及时删除。